HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
+11.3%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$62.7M
AUM Growth
+$62.7M
(+1.8%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-17.92%
Top 10 Holdings %
Top 10 Hldgs %
74.83%
Holding
45
New
9
Increased
5
Reduced
8
Closed
5
Top Buys
| 1 |
AMRI
Albany Molecular Research Inc
AMRI
|
$8.33M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$3.96M |
| 3 |
Pfizer
PFE
|
$3.21M |
| 4 |
ProShares UltraShort NASDAQ Biotechnology
BIS
|
$2.23M |
| 5 |
Sanofi
SNY
|
$1.31M |
Top Sells
| 1 |
ANI Pharmaceuticals
ANIP
|
$11M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$8.44M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
$4.23M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$4.21M |
| 5 |
GSK
GSK
|
$2.45M |
Sector Composition
| 1 | Healthcare | 78.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRI
1
DELISTED
Albany Molecular Research Inc
AMRI
| $8.33M | 5.45% | +448,200 | New | +$8.33M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $6.87M | 4.49% | 130,000 +75,000 | +136% | +$3.96M |
|
|
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $4.88M | 3.19% | 179,481 -155,000 | -46% | -$4.21M |
|
4
Quest Diagnostics
DGX
$20.3B
| $4.47M | 2.93% | 77,208 | – | – |
|
5
Merck
MRK
$210B
| $4.37M | 2.86% | 77,000 | – | – |
|
|
6
ANI Pharmaceuticals
ANIP
$2.03B
| $4.19M | 2.74% | 133,558 -351,852 | -72% | -$11M |
|
7
AstraZeneca
AZN
$248B
| $3.71M | 2.43% | 57,239 -25,000 | -30% | -$1.62M |
|
|
QLTI
8
DELISTED
QLT Inc
QLTI
| $3.48M | 2.28% | 626,639 +100,000 | +19% | +$556K |
|
|
HNT
9
DELISTED
HEALTH NET INC
HNT
| $3.4M | 2.22% | 100,000 | – | – |
|
|
10
Pfizer
PFE
$141B
| $3.21M | 2.1% | +100,000 | New | +$3.21M |
|
|
11
Sanofi
SNY
$121B
| $3.02M | 1.97% | 57,735 +25,000 | +76% | +$1.31M |
|
|
12
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
| $2.23M | 1.46% | +125,000 | New | +$2.23M |
|
|
VXRT
13
DELISTED
Vaxart
VXRT
| $1.5M | 0.98% | 245,507 +40,868 | +20% | +$250K |
|
|
SRNE
14
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.28M | 0.84% | +100,000 | New | +$1.28M |
|
15
ProShares UltraShort Russell2000
TWM
$34.5M
| $1.15M | 0.75% | +25,000 | New | +$1.15M |
|
|
16
Supernus Pharmaceuticals
SUPN
$2.53B
| $954K | 0.62% | 106,735 -944,010 | -90% | -$8.44M |
|
17
Baxter International
BAX
$12.7B
| $736K | 0.48% | 10,000 -10,000 | -50% | -$736K |
|
|
VIRX
18
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $682K | 0.45% | 103,185 +20,000 | +24% | +$132K |
|
19
Rigel Pharmaceuticals
RIGL
$697M
| $582K | 0.38% | 150,000 -50,000 | -25% | -$194K |
|
20
Galmed Pharmaceuticals
GLMD
$6.96M
| $574K | 0.38% | +50,000 | New | +$574K |
|
|
FCSC
21
DELISTED
Fibrocell Science Inc.
FCSC
| $564K | 0.37% | +107,769 | New | +$564K |
|
22
Cytokinetics
CYTK
$4.23B
| $538K | 0.35% | 56,666 | – | – |
|
23
Imunon
IMNN
$15M
| $506K | 0.33% | +150,000 | New | +$506K |
|
|
FURX
24
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $435K | 0.28% | +5,000 | New | +$435K |
|
25
Amicus Therapeutics
FOLD
$2.34B
| $414K | 0.27% | 200,000 -50,000 | -20% | -$104K |
|